
Keywords: مهار کننده فعال کننده پلاسمینوژن-1; PAI-1; plasminogen activator inhibitor-1; uPA; urokinase; tPA; tissue plasminogen activator; NF-κB; nuclear factor kappa-B; LPS; lipopolysaccharide; TNF; tumor necrosis factor; IL-1; interleukin-1; IL-6; interleukin-6; TLR4; toll-like receptor 4; ERK; ex